door Maud van Tol | nov 15, 2022 | Geen categorie
The European Medicines Agency has recommended the antibody nirsevimab for a marketing authorization in the European Union. This means that, when the European Commission accepts this recommendation, the antibody can be used in the EU for the prevention of Respiratory...
door Maud van Tol | okt 25, 2022 | Geen categorie
Share this...FacebookTwitterLinkedin25 oktober 2022Nieuwe AMC spin-off TrianecT opgericht Neuroloog Jonathan Coutinho, klinisch technoloog Wouter Potters en hoogleraar radiologie Henk Marquering van Amsterdam UMC, hebben in september samen met AMC Ventures en het...
door Maud van Tol | okt 11, 2022 | Geen categorie
Share this...FacebookTwitterLinkedin11 oktober 2022PacingCure receives €2.5 Million funding from European Innovation Council AMC Ventures portfolio company PacingCure has received a prestigious EIC Transition grant of 2.5 million euros. PacingCure and will use this...
